| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 1.56e-05 | 33 | 95 | 4 | GO:0000289 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.32e-05 | 14 | 95 | 3 | GO:0060213 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 5.08e-05 | 16 | 95 | 3 | GO:0060211 | |
| Domain | NECAP_PHear | 2.40e-05 | 2 | 92 | 2 | IPR012466 | |
| Domain | M_domain | 2.40e-05 | 2 | 92 | 2 | PF12938 | |
| Domain | GW182_M_dom | 2.40e-05 | 2 | 92 | 2 | IPR026805 | |
| Domain | DUF1681 | 2.40e-05 | 2 | 92 | 2 | PF07933 | |
| Domain | FN3 | 5.72e-05 | 199 | 92 | 7 | PS50853 | |
| Domain | Ago_hook | 7.18e-05 | 3 | 92 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 7.18e-05 | 3 | 92 | 2 | IPR032226 | |
| Domain | Dapper | 7.18e-05 | 3 | 92 | 2 | IPR024843 | |
| Domain | Argonaute_hook_dom | 7.18e-05 | 3 | 92 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 7.18e-05 | 3 | 92 | 2 | PF16608 | |
| Domain | Dapper | 7.18e-05 | 3 | 92 | 2 | PF15268 | |
| Domain | FN3_dom | 7.79e-05 | 209 | 92 | 7 | IPR003961 | |
| Domain | WWE | 1.43e-04 | 4 | 92 | 2 | SM00678 | |
| Domain | WWE-dom_subgr | 1.43e-04 | 4 | 92 | 2 | IPR018123 | |
| Domain | fn3 | 1.50e-04 | 162 | 92 | 6 | PF00041 | |
| Domain | FN3 | 3.07e-04 | 185 | 92 | 6 | SM00060 | |
| Domain | - | 4.16e-04 | 71 | 92 | 4 | 1.10.418.10 | |
| Domain | CH | 4.63e-04 | 73 | 92 | 4 | PS50021 | |
| Domain | CH-domain | 5.13e-04 | 75 | 92 | 4 | IPR001715 | |
| Domain | PDZ | 9.03e-04 | 151 | 92 | 5 | PS50106 | |
| Domain | PDZ | 9.31e-04 | 152 | 92 | 5 | IPR001478 | |
| Domain | WWE | 1.53e-03 | 12 | 92 | 2 | PS50918 | |
| Domain | WWE | 1.53e-03 | 12 | 92 | 2 | PF02825 | |
| Domain | WWE-dom | 1.53e-03 | 12 | 92 | 2 | IPR004170 | |
| Domain | VWD | 2.75e-03 | 16 | 92 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.75e-03 | 16 | 92 | 2 | IPR001846 | |
| Domain | VWFD | 2.75e-03 | 16 | 92 | 2 | PS51233 | |
| Domain | VWD | 2.75e-03 | 16 | 92 | 2 | PF00094 | |
| Domain | UBA-like | 3.88e-03 | 64 | 92 | 3 | IPR009060 | |
| Domain | CH | 4.05e-03 | 65 | 92 | 3 | SM00033 | |
| Domain | CH | 4.99e-03 | 70 | 92 | 3 | PF00307 | |
| Domain | PDZ | 5.21e-03 | 141 | 92 | 4 | PF00595 | |
| Domain | - | 5.36e-03 | 663 | 92 | 9 | 2.60.40.10 | |
| Domain | IGv | 6.05e-03 | 75 | 92 | 3 | SM00406 | |
| Domain | PDZ | 6.17e-03 | 148 | 92 | 4 | SM00228 | |
| Domain | - | 6.47e-03 | 150 | 92 | 4 | 2.30.42.10 | |
| Domain | Ig-like_fold | 7.97e-03 | 706 | 92 | 9 | IPR013783 | |
| Domain | UBA | 9.55e-03 | 30 | 92 | 2 | SM00165 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPEG RTTN TNRC6C MAST2 IFNLR1 DACT1 PTPRF SETD5 PTPRS USP40 NAV2 NAV1 NLE1 RIPOR1 TNKS1BP1 DTX2 ATG9A HECTD1 MED13 | 1.99e-10 | 1105 | 97 | 19 | 35748872 |
| Pubmed | SYNE1 KIAA0232 SPEG TNRC6C SETD5 UBAP2L SPHKAP DENND4B NAV1 RIPOR1 CAMSAP2 | 1.99e-08 | 407 | 97 | 11 | 12693553 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 5.10e-08 | 184 | 97 | 8 | 32908313 | |
| Pubmed | 2.39e-07 | 225 | 97 | 8 | 12168954 | ||
| Pubmed | VANGL2 UBE2O LMO7 TNRC6A NAV2 TMEM131L ROBO2 TNKS1BP1 EIF2AK4 MED13 ZNF646 | 2.78e-07 | 529 | 97 | 11 | 14621295 | |
| Pubmed | 4.37e-07 | 102 | 97 | 6 | 11214970 | ||
| Pubmed | PIK3AP1 MXRA8 KANK2 JMJD1C CEP170 UBE2O NECAP2 MAVS TNRC6A NAV1 TMEM131L HECTD1 | 9.76e-07 | 733 | 97 | 12 | 34672954 | |
| Pubmed | ZSWIM8 GIGYF1 XRCC4 KIAA1549L UBAP2L TMPO ROBO2 GCC1 GRIP2 DTX2 CAMSAP2 | 1.09e-06 | 608 | 97 | 11 | 16713569 | |
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 21718540 | ||
| Pubmed | SEC16B RAP1GAP TOGARAM1 PTGFRN JMJD1C CEP170 KRBA1 DTX2 SPIDR HECTD1 | 1.25e-06 | 493 | 97 | 10 | 15368895 | |
| Pubmed | 5.87e-06 | 42 | 97 | 4 | 23444366 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 8.07e-06 | 361 | 97 | 8 | 26167880 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 8.57e-06 | 364 | 97 | 8 | 24778252 | |
| Pubmed | 1.07e-05 | 103 | 97 | 5 | 10574462 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DCAF6 KIAA0232 FRMPD2 TNRC6C JMJD1C CEP170 SETD5 UBAP2L PTPRS USP40 NAV1 RIPOR1 EIF2AK4 SPIDR HECTD1 | 1.58e-05 | 1489 | 97 | 15 | 28611215 |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 2.30e-05 | 59 | 97 | 4 | 28813667 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23696638 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 2.31e-05 | 3 | 97 | 2 | 31985401 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20139422 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 9784606 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 2.31e-05 | 3 | 97 | 2 | 33656439 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 12079279 | ||
| Pubmed | Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53. | 2.31e-05 | 3 | 97 | 2 | 15158073 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 16881060 | ||
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 2.31e-05 | 3 | 97 | 2 | 34108231 | |
| Pubmed | Dact1-3 mRNAs exhibit distinct expression domains during tooth development. | 2.31e-05 | 3 | 97 | 2 | 20170752 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 12062803 | ||
| Pubmed | DNA hypermethylation is associated with invasive phenotype of malignant melanoma. | 2.31e-05 | 3 | 97 | 2 | 31602702 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 16880270 | ||
| Pubmed | T cells develop normally in the absence of both Deltex1 and Deltex2. | 2.31e-05 | 3 | 97 | 2 | 16923970 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 31670606 | ||
| Pubmed | Identification of novel rare mutations of DACT1 in human neural tube defects. | 2.31e-05 | 3 | 97 | 2 | 22610794 | |
| Pubmed | 2.75e-05 | 209 | 97 | 6 | 36779422 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAP1GAP KIAA0232 GIGYF1 MAST2 CEP170 LMO7 NAV2 NAV1 TNKS1BP1 CAMSAP2 HECTD1 | 2.88e-05 | 861 | 97 | 11 | 36931259 |
| Pubmed | 3.30e-05 | 130 | 97 | 5 | 12421765 | ||
| Pubmed | RAP1GAP SYNE1 PCLO KANK2 CEP170 UBE2O LMO7 UBAP2L PTPRS FGA NAV1 TMPO TNKS1BP1 CAMSAP2 | 4.29e-05 | 1431 | 97 | 14 | 37142655 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 14967925 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 25609814 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 23172285 | ||
| Pubmed | Identification of a family of endocytic proteins that define a new alpha-adaptin ear-binding motif. | 4.60e-05 | 4 | 97 | 2 | 14555962 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 26231120 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 8524829 | ||
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 4.60e-05 | 4 | 97 | 2 | 21063388 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 33087405 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 20181956 | ||
| Pubmed | DELTEX2 C-terminal domain recognizes and recruits ADP-ribosylated proteins for ubiquitination. | 6.55e-05 | 28 | 97 | 3 | 32937373 | |
| Pubmed | 7.18e-05 | 153 | 97 | 5 | 10718198 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 10777529 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 22357843 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 8.47e-05 | 256 | 97 | 6 | 33397691 | |
| Pubmed | 9.40e-05 | 162 | 97 | 5 | 25826454 | ||
| Pubmed | 9.82e-05 | 263 | 97 | 6 | 34702444 | ||
| Pubmed | 1.06e-04 | 87 | 97 | 4 | 12465718 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 19273906 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 19110483 | ||
| Pubmed | OTUD5 MAST2 KANK2 IFNLR1 DACT1 AP1AR DMKN PTPRS FGA RIPOR1 EIF2AK4 MED13 | 1.45e-04 | 1215 | 97 | 12 | 15146197 | |
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 29073098 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 33990333 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 1454056 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 12376545 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 1.60e-04 | 7 | 97 | 2 | 19470757 | |
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 19383768 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 35584177 | ||
| Pubmed | Dynamic microtubules catalyze formation of navigator-TRIO complexes to regulate neurite extension. | 1.60e-04 | 7 | 97 | 2 | 25065758 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.77e-04 | 560 | 97 | 8 | 21653829 | |
| Pubmed | 1.96e-04 | 102 | 97 | 4 | 10231032 | ||
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 24768540 | ||
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 24278020 | ||
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 37591863 | ||
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 28637841 | ||
| Pubmed | An innate antiviral pathway acting before interferons at epithelial surfaces. | 2.13e-04 | 8 | 97 | 2 | 26595890 | |
| Pubmed | 2.59e-04 | 446 | 97 | 7 | 24255178 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 2.64e-04 | 754 | 97 | 9 | 33060197 | |
| Pubmed | Definition of the consensus motif recognized by gamma-adaptin ear domains. | 2.74e-04 | 9 | 97 | 2 | 14665628 | |
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 34908452 | ||
| Pubmed | Interaction between liprin-alpha and GIT1 is required for AMPA receptor targeting. | 2.74e-04 | 9 | 97 | 2 | 12629171 | |
| Pubmed | ZSWIM8 DCAF6 GIGYF1 MAST2 KANK2 VANGL2 CEP170 SETD5 TNRC6A CRNN ZNF646 | 2.83e-04 | 1116 | 97 | 11 | 31753913 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | RAP1GAP MAST2 JMJD1C KBTBD7 DACT1 TMEM44 ROBO2 RIPOR1 OSBP2 ATG9A GPRASP2 | 3.01e-04 | 1124 | 97 | 11 | 21900206 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GIGYF1 XRCC4 CEP170 BBX LMO7 SETD5 DACT3 CRNN NAV1 RIPOR1 TNKS1BP1 CAMSAP2 | 3.12e-04 | 1321 | 97 | 12 | 27173435 |
| Pubmed | 14-3-3ε and NAV2 interact to regulate neurite outgrowth and axon elongation. | 3.41e-04 | 10 | 97 | 2 | 24161943 | |
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 21984185 | ||
| Pubmed | ZNRD2 SYNE1 KANK2 CEP170 UBE2O UBAP2L PTPRS SPHKAP NAV1 CAMSAP2 | 3.62e-04 | 963 | 97 | 10 | 28671696 | |
| Pubmed | 4.17e-04 | 11 | 97 | 2 | 25624497 | ||
| Pubmed | 4.17e-04 | 11 | 97 | 2 | 7832766 | ||
| Pubmed | IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus. | 4.17e-04 | 11 | 97 | 2 | 37703370 | |
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 4.17e-04 | 11 | 97 | 2 | 20351715 | |
| Pubmed | VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation. | 4.17e-04 | 11 | 97 | 2 | 37352355 | |
| Pubmed | 4.17e-04 | 11 | 97 | 2 | 21984184 | ||
| Pubmed | 4.55e-04 | 645 | 97 | 8 | 25281560 | ||
| Pubmed | 4.90e-04 | 496 | 97 | 7 | 31343991 | ||
| Pubmed | 4.95e-04 | 497 | 97 | 7 | 23414517 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.95e-04 | 497 | 97 | 7 | 36774506 | |
| Pubmed | 4.99e-04 | 12 | 97 | 2 | 11591818 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 4.99e-04 | 12 | 97 | 2 | 9624153 | |
| Pubmed | The CEP19-RABL2 GTPase Complex Binds IFT-B to Initiate Intraflagellar Transport at the Ciliary Base. | 4.99e-04 | 12 | 97 | 2 | 28625565 | |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 5.23e-04 | 132 | 97 | 4 | 16944949 | |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 5.24e-04 | 56 | 97 | 3 | 9455484 | |
| Pubmed | 5.52e-04 | 57 | 97 | 3 | 36849460 | ||
| Pubmed | 5.99e-04 | 242 | 97 | 5 | 34011540 | ||
| Pubmed | 6.10e-04 | 59 | 97 | 3 | 26371508 | ||
| Interaction | CEP135 interactions | RTTN TOGARAM1 GIGYF1 TNRC6C CEP170 DACT1 LMO7 TNRC6A NAV1 TMEM131L | 5.13e-07 | 272 | 93 | 10 | int:CEP135 |
| Interaction | TNRC6A interactions | GIGYF1 TNRC6C KANK2 UBE2O UBAP2L TNRC6A TNKS1BP1 EIF2AK4 DTX2 MED13 | 6.69e-07 | 280 | 93 | 10 | int:TNRC6A |
| Interaction | TOP3B interactions | SPEG RTTN TNRC6C MAST2 KANK2 IFNLR1 DACT1 PTPRF SETD5 UBAP2L PTPRS USP40 NAV2 NAV1 NLE1 RIPOR1 TNKS1BP1 DTX2 ATG9A HECTD1 MED13 | 2.62e-06 | 1470 | 93 | 21 | int:TOP3B |
| Interaction | CNOT9 interactions | KIAA0232 GIGYF1 TNRC6C JMJD1C UBAP2L TNRC6A TMEM131L TNKS1BP1 | 1.16e-05 | 231 | 93 | 8 | int:CNOT9 |
| Interaction | JPH4 interactions | 1.56e-05 | 68 | 93 | 5 | int:JPH4 | |
| Interaction | GIGYF1 interactions | 1.80e-05 | 177 | 93 | 7 | int:GIGYF1 | |
| Interaction | CNOT2 interactions | 1.86e-05 | 178 | 93 | 7 | int:CNOT2 | |
| Interaction | MED4 interactions | XRCC4 KANK2 CEP170 UBE2O UBAP2L TNRC6A NAV1 GCC1 HECTD1 MED13 | 4.31e-05 | 450 | 93 | 10 | int:MED4 |
| Interaction | CNOT6L interactions | 7.08e-05 | 93 | 93 | 5 | int:CNOT6L | |
| GeneFamily | PDZ domain containing | 8.92e-05 | 152 | 54 | 5 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 1.14e-04 | 160 | 54 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.35e-03 | 161 | 54 | 4 | 593 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.77e-03 | 21 | 54 | 2 | 813 | |
| GeneFamily | CD molecules|Mucins | 1.77e-03 | 21 | 54 | 2 | 648 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.51e-03 | 25 | 54 | 2 | 775 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SPEG PCLO CPEB3 MUC19 GIGYF1 TNRC6C DACT1 KIAA1549L TNRC6A DACT3 FAM217B NAV1 ROBO2 GRIP2 CAMSAP2 | 8.89e-06 | 1106 | 94 | 15 | M39071 |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 1.03e-08 | 195 | 96 | 8 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 2.00e-07 | 192 | 96 | 7 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-07 | 193 | 96 | 7 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.63e-07 | 200 | 96 | 7 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.63e-07 | 200 | 96 | 7 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.63e-07 | 200 | 96 | 7 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.63e-07 | 200 | 96 | 7 | 631550dc34bcb605ab726645f4024d7828bb7975 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 160 | 96 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 160 | 96 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.68e-06 | 181 | 96 | 6 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 2.85e-06 | 183 | 96 | 6 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.13e-06 | 186 | 96 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.33e-06 | 188 | 96 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-06 | 188 | 96 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 3.65e-06 | 191 | 96 | 6 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-06 | 192 | 96 | 6 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 4.11e-06 | 195 | 96 | 6 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 4.11e-06 | 195 | 96 | 6 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.11e-06 | 195 | 96 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-06 | 195 | 96 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-06 | 196 | 96 | 6 | 784459f9f3614ead947aeb61a873dfd4cbe50641 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.62e-06 | 199 | 96 | 6 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-06 | 199 | 96 | 6 | aca81a879ef9c196bd1885eff4c63ffe6c9682b7 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-06 | 199 | 96 | 6 | 7ebd89dff457f57a549eecee288c7a4b515b4018 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-06 | 199 | 96 | 6 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Transitional_AT2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.76e-06 | 200 | 96 | 6 | dfa897ef5ce4744c77b6e5ee5a0d6d83229d1691 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.76e-06 | 200 | 96 | 6 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.76e-06 | 200 | 96 | 6 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Transitional_AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.76e-06 | 200 | 96 | 6 | 8d1c78dd829cbc290820d5118f24ff7f828a8622 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.76e-06 | 200 | 96 | 6 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 200 | 96 | 6 | b2d61bc3afac0d78aa30082760da5b1a15d1fad2 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 200 | 96 | 6 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Parenchymal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 200 | 96 | 6 | 4e5b6cb014d9bcb58e13c7511c86c43e27c496e4 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Transitional_AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.76e-06 | 200 | 96 | 6 | 992bd6b1feac2afded6eb927ac95ddf5cfef961c | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.00e-05 | 166 | 96 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 166 | 96 | 5 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 166 | 96 | 5 | c11dcf9705b85ac3da6ae86358f5ffd64ae8327e | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.18e-05 | 168 | 96 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 168 | 96 | 5 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 168 | 96 | 5 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 170 | 96 | 5 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 172 | 96 | 5 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 172 | 96 | 5 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-05 | 173 | 96 | 5 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-05 | 174 | 96 | 5 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.07e-05 | 177 | 96 | 5 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.07e-05 | 177 | 96 | 5 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-05 | 181 | 96 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.65e-05 | 182 | 96 | 5 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.65e-05 | 182 | 96 | 5 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 4.65e-05 | 182 | 96 | 5 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-05 | 183 | 96 | 5 | b5d041d0a3506c33de72bf14fa0443f4410fddf1 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.77e-05 | 183 | 96 | 5 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 4.77e-05 | 183 | 96 | 5 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 4.77e-05 | 183 | 96 | 5 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-05 | 183 | 96 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-05 | 183 | 96 | 5 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-05 | 183 | 96 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.77e-05 | 183 | 96 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-05 | 184 | 96 | 5 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-05 | 184 | 96 | 5 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 5.03e-05 | 185 | 96 | 5 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 186 | 96 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.16e-05 | 186 | 96 | 5 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 5.16e-05 | 186 | 96 | 5 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.16e-05 | 186 | 96 | 5 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 187 | 96 | 5 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.29e-05 | 187 | 96 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 187 | 96 | 5 | b827d9da7032bf051756ddf88352af922eb0f87b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 187 | 96 | 5 | 61c00604dda8b36a5c3eea6554e5601aa1b884f7 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 187 | 96 | 5 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 5.43e-05 | 188 | 96 | 5 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-05 | 189 | 96 | 5 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 189 | 96 | 5 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 189 | 96 | 5 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 189 | 96 | 5 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.56e-05 | 189 | 96 | 5 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.56e-05 | 189 | 96 | 5 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 189 | 96 | 5 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.56e-05 | 189 | 96 | 5 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 5.56e-05 | 189 | 96 | 5 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-05 | 189 | 96 | 5 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-05 | 189 | 96 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 5.70e-05 | 190 | 96 | 5 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.70e-05 | 190 | 96 | 5 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 5.70e-05 | 190 | 96 | 5 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.70e-05 | 190 | 96 | 5 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 5.85e-05 | 191 | 96 | 5 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.85e-05 | 191 | 96 | 5 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | 367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-05 | 191 | 96 | 5 | d31975fc33779b0b3ff1a50d7c64fec8d08be4d4 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.85e-05 | 191 | 96 | 5 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.85e-05 | 191 | 96 | 5 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 191 | 96 | 5 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-05 | 191 | 96 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.99e-05 | 192 | 96 | 5 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 5.99e-05 | 192 | 96 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-05 | 192 | 96 | 5 | 790282d4232311df3dac4ad97c80fc53443beccc | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-05 | 192 | 96 | 5 | b2d9bffccd6264b4f12d88a0780646ee0b41969f | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.14e-05 | 193 | 96 | 5 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.14e-05 | 193 | 96 | 5 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 2.72e-04 | 8 | 93 | 2 | C3891448 | |
| Disease | cortical thickness | MDM1 MAST2 JMJD1C VANGL2 DACT1 PTPRF SETD5 TNRC6A NAV2 NAV1 ROBO2 | 7.56e-04 | 1113 | 93 | 11 | EFO_0004840 |
| Disease | 5-methyluridine (ribothymidine) measurement | 8.72e-04 | 14 | 93 | 2 | EFO_0020013 | |
| Disease | decreased susceptibility to hepatitis C infection | 1.15e-03 | 16 | 93 | 2 | EFO_0010101 | |
| Disease | QT interval | 1.52e-03 | 534 | 93 | 7 | EFO_0004682 | |
| Disease | sensory perception of sweet taste | 2.24e-03 | 82 | 93 | 3 | GO_0050916 | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.59e-03 | 24 | 93 | 2 | DOID:12894 (is_marker_for) | |
| Disease | platelet component distribution width | 2.67e-03 | 755 | 93 | 8 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DNWGETTTVVTGTSE | 66 | Q9ULK5 | |
| SEEGTSSSGSKRWVS | 571 | Q5SW79 | |
| NEESWTFSQSGTSGS | 656 | Q8WY36 | |
| SSSVEWSTSGERSAS | 706 | Q9P2K8 | |
| NETTGSSSASISWTL | 746 | Q4VNC1 | |
| TKGTTGDWSSEGCST | 221 | Q86Y34 | |
| STSGNDDSTSLDLEW | 196 | Q63HQ0 | |
| TDEWSSIASSSRGIG | 496 | Q58WW2 | |
| TSSTTGESDTVIWNE | 561 | Q9Y2E6 | |
| RGDWKTDSTSSTASS | 711 | Q6ZUJ8 | |
| TSSWSDQTSGSDITL | 3426 | Q8WXI7 | |
| LTLDTSSTASWEGTH | 5876 | Q8WXI7 | |
| SEGTLTLDTSTTTFW | 8506 | Q8WXI7 | |
| GTPTSFSSSSSTDWD | 461 | A5PL33 | |
| LDWSSSSVSDSDERG | 176 | Q05195 | |
| EGASSSLTVTDSTLW | 66 | P43361 | |
| DSTLWSQSDEGSSSN | 76 | P43361 | |
| GATGGSSAWLDSSSE | 396 | Q7Z434 | |
| SASSQSGGEASLWDI | 651 | O75420 | |
| ASTVDSSWDRAGSSG | 391 | Q8IU57 | |
| SSATTWMEGTGILSS | 281 | A0A1B0GTS1 | |
| TSSTTGETDTVVWNE | 566 | Q86UW9 | |
| VDSTWGSGLVDTITS | 281 | Q8NBH2 | |
| SAADTTSVSSWGGSE | 1401 | Q15652 | |
| TSVSSWGGSEVISSL | 1406 | Q15652 | |
| TTGQAAAESSSAGTW | 3431 | Q2LD37 | |
| GSQFWATEDATTTAS | 3346 | Q9Y6V0 | |
| RSWSSGSSEAGSSSS | 286 | Q92628 | |
| SDVSDSGGNTWSSDS | 421 | Q7Z5P9 | |
| VTESWTAGTSSGGHS | 3111 | Q7Z5P9 | |
| SAEVTGTTGLSAWVT | 4616 | Q7Z5P9 | |
| WDLSGSGSSSKVETS | 306 | Q9NTX9 | |
| WDVSSTTSSEGTVSS | 371 | Q8TC05 | |
| GDSASSQSWTSVLEA | 946 | Q9H7Z3 | |
| ATWSEGSKSSDREGT | 1301 | Q8WWI1 | |
| IREAGTSVSSDFSSW | 86 | A0A1B0GUC4 | |
| SGETWDSKFSTIASS | 491 | Q9NY33 | |
| TDVFWSSLSAETGSL | 396 | Q6ZVL6 | |
| AGITETEWTSGSSKG | 226 | P42167 | |
| SGSSSSFSDDEVWVQ | 656 | Q8WVZ9 | |
| SSATTWMEGTGILSS | 281 | A0A1B0GWH4 | |
| GKGLEWVSSISSSSS | 61 | A0A0B4J1V1 | |
| AEGSTGTSSVDWSSA | 476 | Q969R2 | |
| TGASTESGRQEWSST | 406 | Q9UBG3 | |
| TENTATSITITWDSG | 341 | Q13332 | |
| TAETSLGSEFVTGWT | 801 | Q9ULT8 | |
| EEASWSESGVSSSSG | 131 | Q96CN9 | |
| TTTSDSEESGGLIWS | 771 | Q9NYF0 | |
| SSASSDSDGSGGLVW | 561 | Q96B18 | |
| SFGSTWSTGTTNAVE | 106 | Q8NE35 | |
| SRGDSGSESSWGSST | 296 | Q6E0U4 | |
| SGSVHSAADSSWPTT | 281 | Q68DX3 | |
| GVDARTASSGSSVWE | 676 | Q7Z3C6 | |
| ERGSAGHWTSESSVS | 366 | P02671 | |
| ESSVSGSTGQWHSES | 376 | P02671 | |
| SSVGQVTWQSSGEAS | 121 | Q6P0Q8 | |
| STASESSASLGSEWD | 1106 | O75064 | |
| SSASLGSEWDLSESS | 1111 | O75064 | |
| GSEWDLSESSLSNLS | 1116 | O75064 | |
| WTSTESLCSNASGDS | 81 | Q63ZY3 | |
| DSAVESWDSSATEGG | 781 | Q9C0E4 | |
| DWENASTTSSVASGT | 1331 | Q08AD1 | |
| SATAAASSGLEEWTS | 436 | Q96G74 | |
| TATSVTLTWDSGNSE | 331 | P10586 | |
| ITTGWDESSSISSGL | 406 | Q8NEY1 | |
| SSLGSSFVELASTWE | 61 | Q9P2B2 | |
| DGQDWDAASSSGSSS | 326 | Q86VV8 | |
| SGSGDTTVRFWDLST | 131 | Q9NVX2 | |
| GSVSSAWVSERTGES | 1346 | O75445 | |
| SSSEESTGSWTQLAN | 1511 | Q2M3C7 | |
| ETSTCQADGTWSSPT | 761 | Q9UGT4 | |
| VWGDSISSTAVSTAA | 536 | Q9HCJ0 | |
| EALSVSSGSWSSATV | 66 | Q9HCN2 | |
| TGTGDENSTSATWEE | 291 | O60522 | |
| SWSSADELDTSGSVS | 8671 | Q8NF91 | |
| SWGSWSSTSSSDGDK | 1321 | A2VDJ0 | |
| ESGFWSADETSTASS | 221 | Q96D09 | |
| SADETSTASSFWTGE | 226 | Q96D09 | |
| STASSFWTGEETSVR | 231 | Q96D09 | |
| SWDDSSSVSSGISDT | 946 | Q8IVL1 | |
| SFTLDTWSTSRGDTA | 306 | Q9BX95 | |
| TWSTSRGDTAEILGS | 311 | Q9BX95 | |
| TWLEDSVSTTSGGSS | 611 | P47736 | |
| DNISGGDSSATESWD | 126 | Q9C0A6 | |
| GAASGVATVTFEWTS | 91 | Q9NY91 | |
| NTDESTNSSSVWTLG | 1651 | Q9UHV7 | |
| AWSGASSSESSVGGS | 511 | Q7Z5H3 | |
| WDSDTPSSGSCATVS | 171 | Q86YI8 | |
| QSGSTTTSSWDMGST | 381 | Q14157 | |
| DSTVTSTFWSHGLAE | 776 | Q6ZVD8 | |
| ASWGSEDSLSVASDL | 241 | Q15772 | |
| KSTSGLTDITWSSSG | 91 | Q14159 | |
| LTDITWSSSGSDLSD | 96 | Q14159 | |
| SQTEDVDGTWGSSAA | 1516 | Q9C0C2 | |
| DWEKTGNDGSLTTTT | 296 | Q6IQ55 | |
| LTDGHSAWTGTVSES | 36 | Q13426 | |
| SVEGSTSGASSDEWE | 721 | Q9C0C9 | |
| TVSTDSWGQRLGSSE | 121 | O15015 | |
| GSSSEVSSINSDLEW | 426 | Q2T9K0 | |
| TSSSGETSWSAVLDV | 491 | Q9HCK4 | |
| STGDTTITEFAAWST | 866 | P08922 | |
| SSVAVTEATGGTVWE | 811 | Q96JE7 | |
| LTWASAELGSSTSLE | 161 | O60232 | |
| TSWGRGQDSDSISSS | 1171 | A7E2V4 | |
| EAVSSSWSESGGGLS | 76 | Q9Y4F4 | |
| GTAWSLSSESSDDSS | 376 | Q6ZS17 | |
| AASTADLTDSFGWTS | 111 | Q9NVE5 | |
| TDNGTEAWGSSATQT | 746 | Q8NDV7 | |
| AAASSTSTWGSSSVG | 1096 | Q8NDV7 | |
| AAGSSVVSESAVSWE | 31 | Q9BRK3 | |
| SVSNDLWGDFSTASS | 246 | Q8NC96 | |
| TADIWGDFTKSTGST | 236 | Q9NVZ3 |